Literature DB >> 29158357

Evidence for a Role of Vascular Endothelium in the Control of Arterial Wall Viscosity in Humans.

Frederic Roca1, Michele Iacob1, Isabelle Remy-Jouet1, Jeremy Bellien1, Robinson Joannides2.   

Abstract

Arterial wall viscosity (AWV) is a major cause of energy dissipation along the arterial tree. Its determinants remain controversial but an active endothelial regulation has been suggested. Our objective was to assess in humans the physiological role of endothelium-derived nitric oxide (NO), epoxyeicosatrienoic acids and the effect of modulating smooth muscle tone in the regulation of AWV. We simultaneously measured radial artery diameter, wall thickness, and arterial pressure in healthy volunteers during the local infusion of inhibitors of NO-synthase (NG-monomethyl-l-arginine), epoxyeicosatrienoic acids synthesis by cytochrome P450 (fluconazole), the epoxyeicosatrienoic acids cellular targets calcium-activated potassium channels (tetraethylammonium), alone and in combination. AWV was estimated from the relative viscosity expressed as the ratio of the area of the hysteresis loop of the pressure-diameter relationship to the area under the loading phase. Arterial tone was assessed by measuring change in wall stiffness and midwall stress. NG-monomethyl-l-arginine paradoxically reduced relative viscosity (34.9±8.9%-28.9±8.6%). Conversely, relative viscosity was not modified by fluconazole (33.5±15.5%-32.0±13.6%) but increased by tetraethylammonium (31.7±6.6%-35.7±8.0%). This increase was more marked with NG-monomethyl-l-arginine+fluconazole (31.1±10.7%-43.3±13.2%) and NG-monomethyl-l-arginine+tetraethylammonium (29.5±2.3%-41.5±11.1%) compared with inhibitors alone. Sodium nitroprusside decreased AWV (35.4±2.9%-28.7±2.0%). These effects were associated with parallel change in tone but of different magnitude for similar variations in viscosity, suggesting tone-dependent and independent mechanisms. In conclusion, this is the first demonstration that the endothelial factors, NO and epoxyeicosatrienoic acids, regulate AWV in humans and support the role of arterial tone in this regulation. CLINICAL TRIAL REGISTRATION: URL: https://eudract.ema.europa.eu. Unique identifier: RCB2007-A001-10-53.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  arterial pressure; endothelium; endothelium-dependent relaxing factor; fluconazole; nitric oxide; viscosity

Mesh:

Substances:

Year:  2017        PMID: 29158357     DOI: 10.1161/HYPERTENSIONAHA.117.09870

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

1.  [Renal sympathetic denervation can significantly reduce blood pressure and improve arterial stiffness in hypertensive beagles].

Authors:  F Ye; G Shi; X Wang; S Tu; Z Zhang; L Zeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

2.  Greater arterial wall viscosity in endurance-trained men.

Authors:  Hiroshi Kawano; Meiko Asaka; Kenta Yamamoto; Yuko Gando; Masayuki Konishi; Shizuo Sakamoto; Motohiko Miyachi; Mitsuru Higuchi
Journal:  Eur J Appl Physiol       Date:  2021-04-23       Impact factor: 3.078

3.  Adaptation of Arterial Wall Viscosity to the Short-Term Reduction of Heart Rate: Impact of Aging.

Authors:  Frédéric Roca; Michèle Iacob; Thomas Duflot; Nathalie Donnadieu; Caroline Thill; Jérémy Bellien; Robinson Joannides
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106

4.  Noninvasive Measurement of Time-Varying Arterial Wall Elastance Using a Single-Frequency Vibration Approach.

Authors:  Jia-Jung Wang; Shing-Hong Liu; Wei-Kung Tseng; Wenxi Chen
Journal:  Sensors (Basel)       Date:  2020-11-12       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.